Examkin

Soru

Zorluk: OrtaGynecologic Infections

A 26-year-old woman, gravida 1 para 0, at 10 weeks gestation presents to the clinic for an initial prenatal visit. She reports feeling well, noting only mild morning nausea and bilateral breast tenderness. She describes a slight increase in clear vaginal discharge over the past few weeks but denies any pruritus, malodor, dyspareunia, or dysuria. Her temperature is 37.0°C (98.6°F), blood pressure is 112/72 mmHg, and heart rate is 78/min. Pelvic examination reveals a closed, nulliparous-appearing cervix without friability, erythema, or visible lesions. A small amount of clear, non-malodorous mucus is present in the vaginal vault. Bimanual examination shows a soft, appropriately enlarged uterus with no adnexal tenderness. Routine prenatal laboratory screening is performed. The cervical nucleic acid amplification test (NAAT) returns positive for *Chlamydia trachomatis* and negative for *Neisseria gonorrhoeae*. She has no known drug allergies. Which of the following is the most appropriate management for this patient?

  1. A single oral dose of azithromycinCevap
  2. B
    A 7-day course of oral doxycycline
  3. C
    A single intramuscular injection of ceftriaxone plus a single oral dose of azithromycin
  4. D
    A 7-day course of oral levofloxacin
  5. E
    Reassurance and repeat NAAT screening in the third trimester

Cevap

The most appropriate management is to prescribe a single oral dose of azithromycin.
This patient has an isolated *Chlamydia trachomatis* infection diagnosed via routine prenatal NAAT screening. Although the updated standard of care for uncomplicated chlamydial infection in the general (non-pregnant) population is a 7-day course of oral doxycycline, tetracyclines are strictly contraindicated in pregnancy due to the risk of fetal bone growth inhibition and permanent discoloration of deciduous teeth. Therefore, the preferred first-line treatment for chlamydia in a pregnant patient is a single 1-gram oral dose of azithromycin. An alternative regimen is a 7-day course of oral amoxicillin. Following treatment, pregnant patients should undergo a test of cure 3 to 4 weeks after therapy completion, as well as repeat screening in the third trimester.

Adım Adım Çözüm

1
Interpret the laboratory findings in the context of the clinical presentation.
The patient has an asymptomatic *Chlamydia trachomatis* infection, with *Neisseria gonorrhoeae* definitively ruled out by a negative NAAT.
Accurate interpretation of the NAAT dictates a targeted treatment approach, eliminating the need for empiric dual therapy.
2
Evaluate the patient's systemic status and medical history.
The patient is in the first trimester of pregnancy (10 weeks gestation).
Pregnancy status strictly limits pharmacologic options due to the risk of teratogenicity and fetal harm.
3
Select the appropriate targeted, pregnancy-safe antimicrobial agent.
A single oral dose of azithromycin is chosen to eradicate the chlamydial infection.
Doxycycline (the standard non-pregnant first-line agent) is contraindicated in pregnancy. Azithromycin provides safe, effective, targeted therapy.

Anahtar Kavram

Treatment of isolated *Chlamydia trachomatis* infection in pregnancy requires a targeted, teratogen-free regimen, primarily utilizing a single oral dose of azithromycin, while avoiding contraindicated agents like doxycycline.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru